Back
SPDR® S&P Health Care Services ETF Vs. First Trust Nasdaq Pharmaceuticals ETF Industry Stock Comparison
Sell
46
XHS
SPDR® S&P Health Care Services ETF
Last Price:
94.00
Seasonality Move:
4.7%
Sell
49
FTXH
First Trust Nasdaq Pharmaceuticals ETF
Last Price:
29.16
Seasonality Move:
4.52%
Sell
46
SPDR® S&P Health Care Services ETF (XHS)
is a Sell
Is SPDR® S&P Health Care Services ETF a Buy, Sell or Hold?
- The current SPDR® S&P Health Care Services ETF [XHS] share price is $95.87. The Score for XHS is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- XHS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
First Trust Nasdaq Pharmaceuticals ETF (FTXH)
is a Sell
Is First Trust Nasdaq Pharmaceuticals ETF a Buy, Sell or Hold?
- The current First Trust Nasdaq Pharmaceuticals ETF [FTXH] share price is $28.56. The Score for FTXH is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- FTXH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XHS Stock Price Chart
What is SPDR® S&P Health Care Services ETF's stock price today?
-
The SPDR® S&P Health Care Services ETF share price today is $95.87
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XHS is experiencing selling pressure, which indicates risk of future bearish movement.
FTXH Stock Price Chart
What is First Trust Nasdaq Pharmaceuticals ETF's stock price today?
-
The First Trust Nasdaq Pharmaceuticals ETF share price today is $28.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FTXH is experiencing selling pressure, which indicates risk of future bearish movement.
XHS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.46 | Buy |
Relative Strength Index (14 RSI): | 51.29 | Buy |
Chaikin Money Flow: | -1278 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (93.46 - 96.9) | Buy |
Bollinger Bands (100): | (92.41 - 97.83) | Buy |
FTXH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 49.28 | Sell |
Chaikin Money Flow: | -3055 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.21 - 28.85) | Buy |
Bollinger Bands (100): | (27.89 - 29.17) | Buy |
XHS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 96.44 | Sell |
20-day SMA: | 95.06 | Buy |
50-day SMA: | 95.53 | Buy |
200-day SMA: | 92.72 | Buy |
8-day EMA: | 96.32 | Sell |
20-day EMA: | 95.6 | Buy |
50-day EMA: | 95.39 | Buy |
200-day EMA: | 93.11 | Buy |
FTXH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.67 | Sell |
20-day SMA: | 28.48 | Buy |
50-day SMA: | 28.71 | Sell |
200-day SMA: | 27.83 | Buy |
8-day EMA: | 28.68 | Sell |
20-day EMA: | 28.59 | Sell |
50-day EMA: | 28.6 | Sell |
200-day EMA: | 27.9 | Buy |
SPDR® S&P Health Care Services ETF Earnings Growth & XHS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
First Trust Nasdaq Pharmaceuticals ETF Earnings Growth & FTXH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SPDR® S&P Health Care Services ETF Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
First Trust Nasdaq Pharmaceuticals ETF Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |